會員登入
註冊
NBI與AMEX生技指數各跌3.09%、跌1.67%，NYSE藥業指數跌0.22%。
| 2022年02月－美股7日漲跌幅排名(0225-0304) | |||||
| 個股代碼 | 名稱 | 本周收價(美元) | 上周收價(美元) | 漲跌幅 | 備註 |
| IBB | iShares Biotechnology ETF | 122.57 | 126.29 | -2.95% | |
| #NBI | NASDAQ生物科技指數 | 3887.13 | 4010.91 | -3.09% | |
| #BTK | AMEX生物科技指數 | 4896.2 | 4979.5 | -1.67% | |
| 個股代碼 | 名稱 | 本周收價(美元) | 上周收價(美元) | 漲跌幅 | 分類 |
| AKBA | Akebia Therapeutics | 2.42 | 2.19 | 10.50% | 製藥(併KERX) |
| LLY | Eli Lilly and | 262.87 | 250.85 | 4.79% | 製藥 |
| CI | Cigna | 241.63 | 232.84 | 3.78% | 醫療保健 |
| AMGN | Amgen | 232.91 | 227.03 | 2.59% | 生技 |
| JNJ | Johnson & Johnson | 169.48 | 166 | 2.10% | 製藥 |
| MRK | Merck | 77.83 | 76.32 | 1.98% | 製藥：PD-1 |
| PFE | Pfizer | 48.65 | 47.72 | 1.95% | 製藥 |
| GILD | Gilead Sciences | 61.86 | 61.12 | 1.21% | 生技 |
| BIIB | Biogen | 209.45 | 207.38 | 1.00% | 生技 |
| BMY | Bristol-Myers Squibb | 69.36 | 68.8 | 0.81% | 製藥：PD-1 |
| ABBV | AbbVie | 150.56 | 149.54 | 0.68% | 製藥 |
| REGN | Regeneron Pharmaceuticals | 620.41 | 618.66 | 0.28% | 製藥 |
| ABT | Abbott Laboratories | 121.41 | 122.41 | -0.82% | 製藥 |
| ILMN | Illumina | 323.57 | 329.49 | -1.80% | 生技：醫材 |
| NVS | Novartis AG | 84.74 | 87.63 | -3.30% | 製藥 |
| EDIT | Editas Medicine | 16.06 | 16.9 | -4.97% | 基因編輯 |
| MACK | Merrimack Pharmaceuticals | 5.99 | 6.305 | -5.00% | 台灣授權 |
| AZN | AstraZeneca PLC | 57.47 | 60.58 | -5.13% | 製藥 |
| GSK | GlaxoSmithKline PLC | 40.18 | 42.68 | -5.86% | 製藥 |
| SNY | Sanofi | 48.48 | 53.05 | -8.61% | 製藥 |
| TEVA | Teva Pharmaceutical Industries | 7.46 | 8.36 | -10.77% | 製藥 |
| CRSP | CRISPR Therapeutics AG | 53.19 | 59.73 | -10.95% | 基因編輯 |
| ASLN | ASLAN Pharmaceuticals | 0.76 | 0.878 | -13.44% | 製藥(臺美雙掛牌) |
| BLUE | bluebird bio | 5 | 6.17 | -18.96% | 生技：CART |
| CLLS | Cellectis S.A. | 3.53 | 4.4 | -19.77% | 生技：CART |
| CLVS | Clovis Oncology | 1.52 | 2.04 | -25.49% | 製藥：PARP |
| NTLA | Intellia Therapeutics | 65.04 | 96.36 | -32.50% | 基因編輯 |
